About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- Patients with pelvic fractures in a phase 2 trial (81 individual fractures analysed)
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Phase 2 trial, small, published ahead of print. The result was not statistically significant, so no benefit or harm can be concluded. Number of patients was not read from the abstract record.
Cited in
Pelvic fracture healing: no significant benefit
Abaloparatide · Research finding
Limited
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.